AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 245: R906-R914, 1983;
0363-6119/83 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bie, P.
Right arrow Articles by Warberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bie, P.
Right arrow Articles by Warberg, J.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 245, Issue 6 906-R914, Copyright © 1983 by American Physiological Society


ARTICLES

Effects on intravascular pressures of vasopressin and angiotensin II in dogs

P. Bie and J. Warberg

The effects of 30-min intravenous infusions of 8-arginine vasopressin (AVP) and angiotensin-(1,8)-octapeptide (ANG II) to conscious dogs were studied by measurements of systolic (SABP), mean (MABP), and diastolic arterial blood pressures, central venous pressure (CVP), heart rate (HR), and plasma concentrations of vasopressin (pAVP). Infusion of AVP at six rates (0.4-12.8 ng X min-1 X kg-1) raised mean pAVP by 5-490 pg/ml and increased CVP by 2-10 cmH2O. HR decreased and arterial pressures increased with infusion rates of 1.6-12.8 ng X min-1 X kg-1. However, the increase in SABP was only transient. ANG II increased all arterial pressures; however, it barely changed CVP and did not change HR or pAVP. It is concluded that 1) AVP can elevate MABP without changes in SABP, 2) the effects of AVP on arterial pressures are buffered within 5-15 min, 3) CVP can be increased by doses of AVP that do not affect arterial pressures, and 4) the pressor activity is independent of the presence of ANG II. The results confirm that the cardiovascular response to vasopressin is qualitatively different from that elicited by ANG II.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wamberg, R. R. Plovsing, N. C. F. Sandgaard, and P. Bie
Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R971 - R980.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K. Sander-Jensen, J. Marving, N. H. Secher, I.-L. K. Hansen, J. Giese, J. Warberg, and P. Bie
Does the Decrease in Heart Rate Prevent a Detrimental Decrease of the End-Systolic Volume during Central Hypovolemia in Man?
Angiology, September 1, 1990; 41(9): 687 - 695.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online